Latest Office News

Stakk has executed a five-year US$9 million agreement with US banking technology provider Candescent, with its AI-powered cheque and document intelligence already deployed. The contract commits approximately US$1.8 million in annual revenue through 2030 and is expected to contribute above Stakk’s FY2027 revenue milestone.

DPM Metals says its Vareš operation remains open after Bosnia and Herzegovina’s Constitutional Court found the concession agreement and related land acts were not constitutionally compliant. Authorities now have six months to review the arrangements, leaving the mine operating but its legal framework unresolved.

Sunrise Energy Metals has told ASX that two December 2025 placements became proposed equity issues only after binding terms were executed and board approval obtained. The response comes after ASX questioned the timing of disclosure, the identity of the investor and sharp movements in SRL’s share price and trading volume.

ASX has suspended 15 listed companies from quotation after they failed to lodge required periodic reports by their deadlines. Trading may resume quickly if the outstanding reports are lodged, but the announcement gives no detail on the cause or length of each delay.

Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.

Suncorp Group has rejected speculation that it is in takeover discussions with Tokio Marine after its shares climbed from $19.05 to $20.18 and trading volumes increased. The insurer told the ASX it had received no takeover offer and knew of no undisclosed information explaining the move.

LTR Pharma has completed the final Phase II pharmacokinetic report for SPONTAN, confirming a median 10-minute time to peak concentration against 60 minutes for an oral vardenafil tablet. The result completes the FDA-aligned dataset ahead of planned US submission work, although efficacy in erectile dysfunction patients remains to be tested.

Metallium has completed a 12-hour campaign using three Flash Joule Heating reactors to process platinum-group-metal-bearing catalytic converter material under reactive chlorination conditions. The milestone advances the company’s scale-up program, but recovery results, product economics and feedstock grades remain unverified.

Oregon Group is seeking effective control of New Zealand King Salmon after agreeing to buy half of a 9.87% stake and secure voting rights over another holder’s shares. The proposed transaction would give Oregon control of 50.68% of NZK’s voting rights, subject to several approvals.

Antimony Resources has moved closer to first production in Mexico, but its FY2026 annual report carries a material going-concern warning after a A$7.0 million loss and sharply reduced cash reserves. The company now faces the harder test of turning its Tecomatlán plant and Los Lirios project into cash-generating operations.

Aurora Energy Metals (ASX:1AE) swung to a $21.8 million profit after selling its Oregon uranium project, but the result was driven largely by a non-cash accounting gain. The company’s concentrated Eagle Nuclear Energy stake was valued at about $15.5 million by the annual report date, down from $23.9 million at 30 June.

Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.